Potential Clinical Effects of a Novel Rapid Diagnostic Panel for Pediatric Musculoskeletal Infections

Justin B Searns1,2, Jane Gralla3, Sarah K Parker2

  • 1Division of Hospital Medicine, Children's Hospital Colorado, Aurora.

Insights

A rapid musculoskeletal diagnostic panel (MDP) can speed up pathogen identification and treatment. This diagnostic tool significantly reduces time to definitive antimicrobial therapy and hospital length of stay.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Diagnostics

Background:

  • Accurate and timely diagnosis is crucial for effective management of musculoskeletal infections.
  • Current diagnostic methods can involve delays in pathogen identification and subsequent treatment initiation.
  • Rapid diagnostic panels offer a potential solution to expedite the diagnostic workflow.

Purpose of the Study:

  • To evaluate the impact of a direct-from-source rapid musculoskeletal diagnostic panel (MDP) on clinical decision-making timelines.
  • To compare actual clinical timelines with theoretical timelines incorporating MDP results.
  • To quantify the potential time savings in pathogen identification, antimicrobial therapy, and hospital stay.

Main Methods:

  • Validation of a direct-from-source rapid musculoskeletal diagnostic panel (MDP).
  • Comparison of clinical measures against theoretical time points assuming MDP availability.
  • Analysis of time to pathogen identification, time to definitive antimicrobial therapy, and hospital length of stay.

Main Results:

  • The MDP significantly decreased the time to pathogen identification by 7 hours.
  • The MDP would have reduced the time to definitive antimicrobial therapy by 22 hours.
  • Implementation of the MDP could shorten hospital length of stay by an average of 26.4 hours.

Conclusions:

  • Rapid diagnostic panels like the MDP can substantially improve the efficiency of managing musculoskeletal infections.
  • Early pathogen identification and targeted therapy facilitated by MDPs lead to reduced healthcare resource utilization.
  • The validated MDP demonstrates significant potential for optimizing patient care pathways in musculoskeletal infections.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
286
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
303
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
490
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
319
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
234
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
441